期刊文献+

DFU对骨肉瘤细胞增殖和侵袭能力的影响 被引量:3

The inhibitory effects of DFU on proliferation and invasion of osteosarcoma cells
原文传递
导出
摘要 目的观察选择性环氧合酶-2抑制剂DFU对人骨肉瘤细胞株MG-63增殖和侵袭能力的影响及其对Ang-2基因表达的调控。方法体外培养骨肉瘤细胞株MG-63,免疫荧光法检测Ang-2在MG-63细胞中的表达,应用噻唑蓝(MTT)比色法和形态学检测研究不同浓度DFU对骨肉瘤细胞株MG-63的生长抑制作用,Boyden小室体外侵袭实验检测其对骨肉瘤细胞侵袭能力的影响,RT—PCR法分析DFU对骨肉瘤细胞株MG-63中Ang-2基因表达的影响。结果免疫荧光染色结果显示Ang-2在骨肉瘤细胞株MG-63中呈阳性染色,MTT法和形态学检测提示DFU可抑制骨肉瘤细胞株MG-63的增殖,并具有剂量依赖性,在DFU浓度为200μmol/L时,对细胞生长有明显的抑制作用。Boyden小室体外侵袭实验显示DFU可降低骨肉瘤细胞的侵袭能力,在DFU浓度为200μmol/L时,作用最显著。逆转录-聚合酶链反应(RT—PCR)分析显示经DFU作用后的骨肉瘤细胞株MG-63表达Ang-2较用药前明显下降。结论DFU对骨肉瘤细胞株MG-63的增殖有抑制作用,其可能通过抑制Ang-2的表达,降低其侵袭能力。 Objective To investigate the inhibitory effects of DFU, a Cyclooxygenase-2-selectedinhibitor, on proliferation and invasion of osteosarcoma cells line MG-63, and the influences of DFU on the expression of angiopoietin-2 (Ang-2) in MG-63 cells. Methods Osteosarcoma cells line MG-63 was cultured in vitro. The expression of Ang-2 in MG-63 was observed by immunofluorescence. Methyl thiazolyl tetrazolium (MTT) and morphology were used to study the inhibitory effects of DFU with different concentration on osteosarcoma cells line MG-63. Boyden chamber in vitro invasion assay was applied to observe the changes of invasion capability. The expression of Ang-2 of osteosarcoma cells line MG-63 was analysed by RT-PCR. Results Positive staining was seen in the cells line MG-63 by immunofluorescence. The inhibition rate of osteosarcoma cells line MG-63 was higher when treated with DFU and the rate reached the peak when the concentration of DFU was 200 μmol/L. The invasion ability was remarkably decreased after treated with DFU. Ang-2 mRNA expression of osteosarcoma cells line MG-63 declined obviously than before medication. Conclusion DFU has lethal effect on osteosarcoma cells line MG-63. It may inhibit the proliferation and invasion of osteosarcoma cells line MG-63 by inhibiting the expression of Ang-2.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第11期1549-1551,共3页 Chinese Journal of Experimental Surgery
关键词 DFU 骨肉瘤 ANG-2 DFU Osteosarcoma Ang-2
  • 相关文献

参考文献7

  • 1Lewis CE, De Palma M, Naldini L. Tie2-expressing monocytes and tumor angiogenesis:regulation by hypoxia and angiopoietin-2. Cancer Res,2007,67:8429-8432.
  • 2Helfrich I, Edler L, Sucker A, et al. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res ,2009,15 : 1384-1392.
  • 3Tan ML, Choong PF, Dass CR. Osteosarcoma: Conventional treatment vs. gene therapy. Cancer Biol Ther,2009,8 : 106-117.
  • 4John-Aryankalayil M, Palayoor ST, Cerna D, et al. NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells. Mol Cancer Ther, 2009,8:261-273.
  • 5Kumpers P, Koenecke C, Hecker H, et al. Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. Blood,2008,112:2139-2148.
  • 6Yonemoto T, Ishii T, Takeuchi Y, et al. Recently intensified chemotherapy for high-grade osteosarcoma may affect fertility in long-term male survivors. Anticaneer Res ,2009,29:763-767.
  • 7Chang CL, Ma B, Pang X, et al. Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer. Mol Ther,2009,17 : 1365-1372.

同被引文献13

  • 1胡新华,张强,杨军,杨德华,刘程伟,张志深.RNA干扰沉默雷帕霉素靶蛋白基因表达对血管平滑肌细胞增殖活性的影响[J].中华实验外科杂志,2006,23(10):1181-1183. 被引量:8
  • 2Guo WC, Zhao SH, Yu L, et al. Expression and its clinical significance of heat shock protein gp96 in human osteosarcoma. Neoplasma, 2010,57:62-67.
  • 3Liang X, Da M, Zhuang Z, et al. Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell Biol Int, 2009,33: 119-124.
  • 4Jaworski J, Sheng M. The growing role of roTOR in neuronal develop- ment and plasticity. Mol Neurobiol, 2006,34 : 205-219.
  • 5Papadimitrakopoulou V,Adjei AA. The Akt/mTOR and mitogen-activated protein kinaSe pathways in lung cancer therapy. J Thorac Oncol,2006,1:749-751.
  • 6Geryk-Hall M, Hughes DP. Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions. Curr Oncol Rep, 2009, 11:446-453.
  • 7Ghayad SE, Bieche I, Vendrell JA, et al. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer ceils at the cell proliferation and gene-expression levels. Cancer Sci,2008,99: 1992- 2003.
  • 8Mueller MT, Hermann PC,Witthauer J,et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology ,2009,137 : 1102-1113.
  • 9Hudes GR. mTOR as a target for therapy of renal cancer. Clin Adv Hematol Oncol,2007 ,5 :772-774.
  • 10Chang Q, Chen E, Hedley DW. Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models. Cancer Biol Ther,2009,8:1893-1901.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部